![\"\"\/](\"https:\/\/s3-symbol-logo.tradingview.com\/unitedhealth.svg\"){kind=logo}
UNH<\/a> :UnitedHealth Group (UNH) has tanked ~50% in the past year, but the July 29 (VERY SOON) earnings could flip the script. As a historically dominant player, UNH is now undervalued amid sector weakness, offering massive upside if regulatory fears ease. <\/p>\n
Here’s my full bull case. \ud83d\udc47 FUNDAMENTAL ANALYSIS<\/p>\n
Why the Sell-Off? A Perfect Storm of Bad News
UNH crushed the market for 15 straight years (2009-2023) with positive returns, predictable EPS growth, and 134% gains over the last decade.
But 2024 brought chaos:<\/p>\n
Feb: Massive cyber attack caused a one-time EPS hit (non-recurring).
Ongoing: DOJ antitrust probe, criminal fraud investigation, rising Medicare costs, and Optum losses.
April: Disastrous Q1 earnings miss + lowered guidance.
Leadership drama: CEO death.
This erased gains (down 7% over 5 years), amplified by healthcare sector outflows\u2014the biggest since 2020. But is this overblown? Signs point to yes. The markets almost always overreact to bad news. <\/p>\n
Bullish Signals: Insiders Betting Big
The tide is turning:<\/p>\n
Insider Buying Boom: $32M+ in 2024 (vs. $6.6M in 2019), including new CEO\/CFO\u2014highest in 15 years.
Congress Buying: Q2 2024 saw net purchases for the first time in 5 years (vs. historical selling).
DOJ Shift: Probe refocusing on pharmacy benefits (PBM) unit, dropping acquisition\/monopoly scrutiny\u2014implies no major findings. Great news!
Sector Tailwinds: Healthcare is one of 3 S&P sectors below historical valuations. Super investors (usually tech-obsessed) are piling in, despite the sector’s -10% YTD vs. S&P’s +13%.
Plus, UNH’s dividend yield is at a record ~3% (vs. 1.5% avg), with 16%+ historical growth and 100%+ free cash flow conversion. Rare combo of yield + growth!<\/p>\n
Valuation: Screaming Buy?<\/p>\n
UNH trades at PE ~11.9 (vs. 10-year avg 23)\u2014a steal.
Analysts project 16.7% EPS CAGR through 2029.
Conservative Scenario: 16.5% EPS growth + PE to 16.5 = $780\/share by 2030 (173% total return, 18% CAGR ex-dividends).
Optimistic: PE back to 23 = $1,084\/share (280% return).<\/p>\n
Models confirm:<\/p>\n
DCF (8% FCF growth): ~$484\/share (70% upside).
DDM (7% div growth): ~$607\/share (112% upside).
Blended Fair Value: ~$545\/share (75-90% upside from ~$300). Buy below $436 for 20% safety margin.
Still, there is fear of DOJ uncertainty\u2014investors hate unpredictability and that’s why the stock is so low. <\/p>\n
Key Catalyst: July 29 Earnings
This could be UNH’s “most important report ever.” Watch for:<\/p>\n
Regulatory\/legal updates (DOJ progress).
Full-year guidance revisions.
Metrics like medical loss ratio and PBM performance.<\/p>\n
Positive news = potential rocket \ud83d\ude80. Expectations are low (20 bearish EPS revisions vs. 0 bullish), so a beat could spark volatility… upward.<\/p>\n
Risks: Not Without Bumps<\/p>\n
Regulatory escalation (e.g., PBM issues) could tank it further.
Short-term headwinds: Medicare costs, sector selling.
Mitigants: DOJ de-risking, strong FCF buffer, insider confidence. Enter cautiously\u2014size positions small.<\/p>\n
TECHNICAL ANALYSIS<\/p>\n
I also did a little technical analysis:<\/p>\n
UNH price is at a resistance level
My EVaR indicator tells me we are in a low-risk area
RSI says the stock is oversold
I added the different price targets for better visualization<\/p>\n
THE PLAN<\/p>\n
My plan:
Later today, I will allocate 1% to 1.5% of my portfolio to the stock. If it drops, I will continue to DCA. The stock is already really beaten down, and I think a company this large cannot drop much more. <\/p>\n
Quick note: I’m just sharing my journey – not financial advice! \ud83d\ude0a<\/p>\n","protected":false},"excerpt":{"rendered":"The healthcare sector has been in decline, which creates interesting opportunities. I recently talked about a few pharma…\n","protected":false},"author":2,"featured_media":22756,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,137,500],"class_list":["post-22755","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-health","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/22755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=22755"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/22755\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/22756"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=22755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=22755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=22755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}